These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 381835
21. [Daily profile of pulse rate and blood pressure. Use of betablocker-diuretic combination (author's transl)]. Kirchhoff HW. MMW Munch Med Wochenschr; 1981 Jan 23; 123(4):124-8. PubMed ID: 6783878 [No Abstract] [Full Text] [Related]
22. [Long-term treatment of hypertension with a beta blocker-diuretic combination]. Hoffmann J, Grund R, Schrey A. ZFA (Stuttgart); 1983 Nov 10; 59(31):1773-7. PubMed ID: 6659669 [No Abstract] [Full Text] [Related]
23. [A beta receptor blocker-diuretic combination in elderly hypertensive patients at health resorts]. Kirchhoff HW. ZFA (Stuttgart); 1983 Jul 31; 59(21):1188-91. PubMed ID: 6636994 [No Abstract] [Full Text] [Related]
27. [Betamed in the treatment of psychogenic disorders with a somatic component]. Jellinger K. Wien Med Wochenschr; 1983 Sep 30; 133(18):463-7. PubMed ID: 6359726 [Abstract] [Full Text] [Related]
29. [Potassium-sparing effect of triamterene in a 3-component combination preparation for the therapy of hypertension]. Nagler J, Dittrich H. Wien Klin Wochenschr; 1986 Jan 24; 98(2):49-53. PubMed ID: 3962310 [Abstract] [Full Text] [Related]
30. [Clinical testing of a new beta blocking agent--atenolol--in hypertension]. Hansson L, Henningsen NC, Jameson S, Karlberg BE, Westerlund A, Aberg H. Lakartidningen; 1976 Aug 18; 73(34):2741-4. PubMed ID: 787700 [No Abstract] [Full Text] [Related]
31. [Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo]. Cherchi A, Sau F, Mercuro G, Seguro C, Lai O. Clin Ter; 1985 May 31; 113(4):301-6. PubMed ID: 3893868 [No Abstract] [Full Text] [Related]
32. [Effect of a .2 percent acqueous bupranolol solution in chronic glaucoma with open iridocorneal angle]. Oancea I, Trif V. Med Welt; 1979 Dec 07; 30(49):1863-5. PubMed ID: 545072 [No Abstract] [Full Text] [Related]
33. [Ocular hypotensive action of bupranolol solutions]. Càlugăru M, Oancea I. Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1987 Dec 07; 31(1):43-6. PubMed ID: 2955468 [No Abstract] [Full Text] [Related]
34. [Driving behavior of cardiovascular patients as affected by beta receptor blockers]. Schmidt U, Hoburg A, Brendemühl D, Delbeck HW, Buck W, Engels K. Med Klin; 1980 Dec 19; 75(26):913-6. PubMed ID: 7464643 [Abstract] [Full Text] [Related]
38. [Therapy of essential hypertension using a new beta-receptor blockader (timolol maleate) combined with hydrochlorothiazide]. Heinze A, Wessels F. Verh Dtsch Ges Inn Med; 1974 Dec 19; 80():272-4. PubMed ID: 4156115 [No Abstract] [Full Text] [Related]
39. The intraocular pressure responses of low-dose bupranolol (Ophtorenin) and methazolamide (Neptazane) in glaucomatous eyes. A controlled clinical study. Leydhecker W, Krieglstein GK. Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Apr 02; 210(2):135-40. PubMed ID: 373489 [Abstract] [Full Text] [Related]
40. [Our experience on the clinical use of nadolol]. Trinchero R, Moratti M, Ghisio A, Pomari F, Artesani S, Barbano G. Minerva Cardioangiol; 1985 Oct 02; 33(10):629-34. PubMed ID: 2867492 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]